Compare Colgate-Palmolive Company (CL) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs ResMed Inc. — how do they compare? Colgate-Palmolive Company trades at $92 (market cap $73.59B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: Colgate-Palmolive Company is far larger — about 2.3× ResMed Inc.'s market cap, and Colgate-Palmolive Company pays the higher dividend (2.3%). Which is the better fit depends on your goals.
| CL | RMD | |
|---|---|---|
Market Cap | $73.59B | $32.61B |
Sector | Consumer Staples | Health |
52-Week High | $99.14 | $293.73 |
52-Week Low | $74.98 | $182.82 |
Enterprise Value | $80.07B | $31.97B |
Dividend Yield | 2.3% | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
